Shunji Matsuki

ORCID: 0000-0002-4867-7120 · 4 papers in corpus · active 1994-2025

Study types

  • letter 2
  • other 1

Condition tags

  • mesh:D004715 2
  • endometriosis 2
other 2025
Safety and pharmacology of AMY109, a long-acting anti-interleukin-8 antibody, for endometriosis: a double-blind, randomized phase 1 trial
F&S reports ·doi:10.1016/j.xfre.2025.04.009

OBJECTIVE: To evaluate the safety and pharmacokinetics/pharmacodynamics of AMY109, an anti-interleukin-8 recycling antibody in a first-in-human phase 1 trial in healthy volunteers (HVs) and patients with endometriosis. DESIGN: A multicente…

2021
SARS-CoV-2 seroprevalence among healthcare workers in general hospitals and clinics in Japan
·doi:10.1101/2021.01.23.21249922
letter 1994
Histologic observations of the adenomyotic glandular epithelium after hormonal treatment for endometriosis
International Journal of Gynecology & Obstetrics ·doi:10.1016/0020-7292(94)90579-7
letter 1994
Low rate of histological confirmation of macroscopic endometriotic lesions
International Journal of Gynecology & Obstetrics ·doi:10.1016/0020-7292(94)90359-x